JP2006517940A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006517940A5 JP2006517940A5 JP2006501857A JP2006501857A JP2006517940A5 JP 2006517940 A5 JP2006517940 A5 JP 2006517940A5 JP 2006501857 A JP2006501857 A JP 2006501857A JP 2006501857 A JP2006501857 A JP 2006501857A JP 2006517940 A5 JP2006517940 A5 JP 2006517940A5
- Authority
- JP
- Japan
- Prior art keywords
- enantiomers
- enantiomer
- side effects
- doses
- hyperalgesia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0303615.9A GB0303615D0 (en) | 2003-02-17 | 2003-02-17 | Use of organic compounds |
| PCT/EP2004/001451 WO2004071513A1 (en) | 2003-02-17 | 2004-02-16 | Use of r-10-hydroxy-10, 11-dihydro-carbamazepine in neuropathic pain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006517940A JP2006517940A (ja) | 2006-08-03 |
| JP2006517940A5 true JP2006517940A5 (https=) | 2007-04-12 |
Family
ID=9953162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006501857A Pending JP2006517940A (ja) | 2003-02-17 | 2004-02-16 | 神経障害性疼痛におけるｒ−１０−ヒドロキシ−１０，１１−ジヒドロ−カルバマゼピンの使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US20060166967A1 (https=) |
| EP (1) | EP1596865A1 (https=) |
| JP (1) | JP2006517940A (https=) |
| CN (1) | CN1750826A (https=) |
| AU (1) | AU2004212327A1 (https=) |
| BR (1) | BRPI0407529A (https=) |
| CA (1) | CA2516265A1 (https=) |
| GB (1) | GB0303615D0 (https=) |
| MX (1) | MXPA05008711A (https=) |
| PL (1) | PL376755A1 (https=) |
| WO (1) | WO2004071513A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060252745A1 (en) | 2005-05-06 | 2006-11-09 | Almeida Jose L D | Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use |
| EP2380575B1 (en) * | 2005-05-06 | 2015-02-25 | Bial-Portela & CA, S.A. | Eslicarbazepine acetate and use |
| GB0517740D0 (en) * | 2005-08-31 | 2005-10-12 | Novartis Ag | Organic compounds |
| GB0603008D0 (en) * | 2006-02-14 | 2006-03-29 | Portela & Ca Sa | Method |
| GB0700773D0 (en) | 2007-01-15 | 2007-02-21 | Portela & Ca Sa | Drug therapies |
| WO2011017319A1 (en) * | 2009-08-03 | 2011-02-10 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Methods of treating disorders associated with protein polymerization |
| US8809617B2 (en) | 2009-11-05 | 2014-08-19 | The University of Pittsburgh—Of the Commonwealth System of Higher Education | Automated high-content live animal drug screening using C. elegans |
| US9072772B2 (en) | 2009-11-05 | 2015-07-07 | University of Pittsburgh—of the Commonwealth System of Higher Education | Methods of treating disorders associated with protein aggregation |
| CN116063231A (zh) * | 2021-10-29 | 2023-05-05 | 上药康丽（常州）药业有限公司 | 一种s-利卡西平的回收方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH505101A (de) * | 1969-03-31 | 1971-03-31 | Ciba Geigy Ag | Verfahren zur Herstellung von neuen Azepinderivaten |
| EP0435826A1 (de) * | 1989-12-27 | 1991-07-03 | Ciba-Geigy Ag | Intravenöse Lösungen für Status Epilepticus |
| US5534495A (en) * | 1993-05-25 | 1996-07-09 | Advanced Peptides And Biotechnology Sciences | Treatment of non-HIV neuropathic pain syndromes |
| US5688830A (en) * | 1996-01-25 | 1997-11-18 | Syntex (U.S.A.) Inc. | Treatment of neuropathic pain |
| GB0112812D0 (en) * | 2001-05-25 | 2001-07-18 | Portela & Ca Sa | Mthd for preparation of 10, 11-dihydro-10-hydroxy-5H-dibenz/B,F/azepine-5-c arboxamide and 10,11-dihydro-10-oxo-5H-dibenz/B,F/azepine-5-carb oxamide therefrom |
| ES2314111T3 (es) * | 2001-11-12 | 2009-03-16 | Novartis Ag | Monohidroxicarbamezepina para uso en la preparacion de un medicamento para el tratamiento del trastorno de afectivo y de atencion y dolor neuropatico. |
| JP2005538126A (ja) * | 2002-08-06 | 2005-12-15 | ノバルティス アクチエンゲゼルシャフト | 耳鳴の処置のためのカルボキサミドの使用 |
| GB0223224D0 (en) * | 2002-10-07 | 2002-11-13 | Novartis Ag | Organic compounds |
-
2003
- 2003-02-17 GB GBGB0303615.9A patent/GB0303615D0/en not_active Ceased
-
2004
- 2004-02-16 BR BRPI0407529-3A patent/BRPI0407529A/pt not_active IP Right Cessation
- 2004-02-16 WO PCT/EP2004/001451 patent/WO2004071513A1/en not_active Ceased
- 2004-02-16 PL PL376755A patent/PL376755A1/pl not_active Application Discontinuation
- 2004-02-16 CA CA002516265A patent/CA2516265A1/en not_active Abandoned
- 2004-02-16 AU AU2004212327A patent/AU2004212327A1/en not_active Abandoned
- 2004-02-16 EP EP04711348A patent/EP1596865A1/en not_active Withdrawn
- 2004-02-16 JP JP2006501857A patent/JP2006517940A/ja active Pending
- 2004-02-16 MX MXPA05008711A patent/MXPA05008711A/es not_active Application Discontinuation
- 2004-02-16 CN CNA2004800044023A patent/CN1750826A/zh active Pending
-
2005
- 2005-02-16 US US10/545,410 patent/US20060166967A1/en not_active Abandoned
-
2008
- 2008-10-30 US US12/261,655 patent/US20090054404A1/en not_active Abandoned
-
2009
- 2009-12-08 US US12/633,231 patent/US20100120746A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005518433A5 (https=) | ||
| IL232313A (en) | Modulators of indoleamine 2,3-dioxigenase and methods of use of the above | |
| WO2007112014A3 (en) | New therapeutic combinations for the treatment of depression | |
| CY2013023I2 (el) | Φαρμακο για την υπερδραστηρια ουροδοχο κυστη περιλαμβανον παραγωγο ανιλιδιου οξικου οξεοσως το ενεργο συστατικο | |
| NO2017047I1 (no) | Tofacitinib, evt. i form av et farmasøytisk akseptabelt salt, inkludert citratsalt | |
| EP2349279A4 (en) | MODIFIERS OF ALDEHYDE DEHYDROGENASE AND METHODS OF USE THEREOF | |
| JP2009517473A5 (https=) | ||
| EA200701146A1 (ru) | Композиция, содержащая орнитин и фенилацетат или фенилбутират, для лечения печеночной энцефалопатии | |
| JP2006517940A5 (https=) | ||
| EA201001669A1 (ru) | Замещенные пиримидин-5-карбоксамиды 281 | |
| EA200970483A1 (ru) | Применение пролекарств габапентина и прегабалина для лечения шума в ушах | |
| GEP20135803B (en) | Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives | |
| WO2010044585A3 (en) | Piperidine compounds, pharmaceutical composition comprising the same and its use | |
| JP2013537237A5 (https=) | ||
| ATE404206T1 (de) | Orale suspension mit meloxicam | |
| WO2006116626A3 (en) | Methods and compositions for treating pain | |
| WO2006119389A3 (en) | Quinine-containing controlled-release formulations | |
| DE502005007791D1 (de) | Wässrige antitranspirant formulierung | |
| MA32480B1 (fr) | Compositions pédiatriques pour le traitement de la sclérose en plaques | |
| WO2013062442A3 (ru) | Композиция для лечения рассеянного склероза (варианты) | |
| ITMI20040954A1 (it) | Derivati del 3,6-diazabiciclo 3.1.i.eptano ad attivita' analgesica | |
| DE602005025767D1 (de) | Orale tedisamilformulierungen mit magenretentionseigenschaften und verzögerter freisetzung | |
| JP2012097034A5 (https=) | ||
| FR2886846B1 (fr) | Nouvelles utilisations de derives du glycerol, notamment dans le domaine cosmetique | |
| EP1813600A4 (en) | N-N-ACYLOXYPROPYL-LYSINE METHYL ESTER AND N, N-BIS (N-ACYLOXYPROPYL) LYSINE METHYL ETHER COMPOUNDS AND THEIR USE AS SURFACE ACTIVE AGENTS WITH ANTIMICROBIAL EFFECT |